| Suspended | Cannabichromene Safety in Rheumatoid Arthritis NCT07087938 | Crystal Lederhos Smith | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis NCT07412704 | Bristol-Myers Squibb | Phase 1 / Phase 2 |
| Not Yet Recruiting | Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis NCT06016517 | Tufts Medical Center | — |
| Recruiting | Fucoidan in the Treatment of Active Rheumatoid Arthritis NCT07045896 | Peking University People's Hospital | N/A |
| Recruiting | Pain in Inflammatory Joint Diseases NCT06718569 | Diakonhjemmet Hospital | — |
| Recruiting | A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) NCT07176390 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory R NCT07017686 | The Bionics Institute of Australia | N/A |
| Not Yet Recruiting | Cellular and Molecular Analysis of Synovial Tissue of Patients With Arthritis NCT06737952 | University Hospital, Basel, Switzerland | — |
| Recruiting | Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Dise NCT06842316 | Centre Hospitalier Régional d'Orléans | — |
| Not Yet Recruiting | Combining Virtual Reality and Hypnosis to Alleviate Chronic Pain in Elderly Patients with Hand Arthritis NCT06833905 | Ciusss de L'Est de l'Île de Montréal | N/A |
| Withdrawn | Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis NCT02720874 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | N/A |
| Recruiting | Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Stu NCT06528431 | Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
| Not Yet Recruiting | Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand Arthritis NCT06077890 | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | N/A |
| Completed | Self-management Nursing Intervention for Women With Rheumatoid Arthritis NCT06337370 | Universidad Nacional de Colombia | N/A |
| Recruiting | Impact of a High-fiber Diet on the Microbiome and Disease Activity in Patients With Rheumatoid Arthritis NCT06492200 | Wuerzburg University Hospital | N/A |
| Not Yet Recruiting | Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IM NCT06273306 | Instituto de Investigación Hospital Universitario La Paz | N/A |
| Recruiting | A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants NCT06246123 | Eisai Korea Inc. | — |
| Completed | Defining Stress REsilience And Mindfulness Effects in Rheumatoid Arthritis NCT06276387 | University of California, San Francisco | N/A |
| Completed | A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] NCT05796245 | Pfizer | — |
| Completed | Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Facto NCT05855109 | Boehringer Ingelheim | — |
| Recruiting | R-2487 in Patients With Rheumatoid Arthritis NCT05961592 | Rise Therapeutics LLC | Phase 1 |
| Completed | A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoi NCT06028438 | Janssen Research & Development, LLC | Phase 2 |
| Recruiting | Fecal Microbial Transplantation for Rheumatoid Arthritis Trial NCT05790356 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism NCT05961267 | University Hospital, Bordeaux | — |
| Recruiting | IMPACT - AndHealth Autoimmune Research Registry NCT05883371 | AndHealth | — |
| Completed | Effectiveness of Therapeutic Exercise on the Gut Microbiome in Chronic Widespread Pain Patients. NCT05932433 | Universidad Rey Juan Carlos | N/A |
| Terminated | A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis NCT06087406 | IGM Biosciences, Inc. | Phase 1 |
| Unknown | Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthr NCT02903212 | Centre Hospitalier Universitaire de Besancon | Phase 1 / Phase 2 |
| Completed | Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis NCT06800157 | Shanghai Longwood Biopharmaceuticals Co., Ltd. | Phase 2 |
| Recruiting | Ultrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach NCT05717179 | Italian Society for Rheumatology | N/A |
| Unknown | Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis NCT05508815 | Beijing University of Chinese Medicine | EARLY_Phase 1 |
| Withdrawn | A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab NCT05304130 | GlaxoSmithKline | Phase 1 |
| Unknown | Distress in Rheumatoid Arthritis Patients NCT06068920 | Bozyaka Training and Research Hospital | — |
| Unknown | Periodontal Therapy in Patients With Rheumatoid Arthritis NCT05502601 | Federal University of Rio Grande do Sul | N/A |
| Completed | A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A R NCT05487703 | Pfizer | — |
| Completed | This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking NCT05375942 | Pfizer | — |
| Completed | Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in Peop NCT05572567 | Pfizer | — |
| Unknown | Accelerometry in Follow up of Arthritis - a Pilot Study NCT05301621 | Helse Forde | — |
| Unknown | Omega-3 and Exercise in Rheumatoid Arthritis People NCT05945693 | Instituto de Ciencias de la Salud, Universidad de O'Higgins | N/A |
| Recruiting | Novel Complex Radiodiagnostics of Peripherial Arthropathies NCT05657847 | Semmelweis University | — |
| Recruiting | The Clinical Efficacy of Immunomodulators in RA Patients NCT05626348 | Qilu Hospital of Shandong University | Phase 4 |
| Completed | Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthriti NCT05198310 | Kiniksa Pharmaceuticals, Ltd. | Phase 2 |
| Completed | A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arth NCT04991753 | Janssen Research & Development, LLC | Phase 2 |
| Recruiting | Chronic Pain in Rheumatoid Arthritis NCT05038553 | Northwestern University | — |
| Completed | Effects of a Mobile Application RA Joint Protection and Activity Self-management Program NCT05570175 | Chang Gung Memorial Hospital | N/A |
| Terminated | Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis NCT04842981 | University of Southern Denmark | Phase 1 / Phase 2 |
| Unknown | Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis NCT04884880 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | N/A |
| Recruiting | Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis. NCT05062421 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | — |
| Unknown | Adaptation of EDAQ Into Turkish, Examining The Reliability and Validity For People With RA NCT05244824 | Hacettepe University | — |
| Active Not Recruiting | Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty NCT04618016 | Aesculap AG | — |
| Unknown | PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors NCT04821206 | Liga Panamericana de Asociaciones de Reumatologia (PANLAR) | — |
| Withdrawn | Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis NCT04117165 | University Hospital, Grenoble | N/A |
| Active Not Recruiting | INFINITY™ With ADAPTIS™ Technology Study NCT04594993 | Stryker Trauma and Extremities | — |
| Unknown | An Exploratory Clinical Study on Autophagy During Fasting NCT04739852 | Charite University, Berlin, Germany | N/A |
| Completed | A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients W NCT04721808 | Pfizer | — |
| Completed | Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy NCT04721821 | Pfizer | — |
| Completed | Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis. NCT06656169 | Instituto Mexicano del Seguro Social | Phase 1 / Phase 2 |
| Active Not Recruiting | Methotrexate and Metformin in Rheumatoid Arthritis Patients NCT04196868 | University Hospital, Bordeaux | Phase 2 |
| Active Not Recruiting | Bone Erosions in Rheumatoid Arthritis - Characterization Evaluated by Imaging and Histology NCT04645381 | University of Aarhus | — |
| Withdrawn | ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis NCT03428763 | Frederiksberg University Hospital | N/A |
| Unknown | Comparative Effectiveness Research of Electroacupuncture and TENS in Patients With Rheumatoid Arthritis NCT04521998 | China Medical University Hospital | N/A |
| Unknown | The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA NCT04973787 | Universidade Nova de Lisboa | — |
| Recruiting | Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response. NCT04731831 | Aalborg University Hospital | — |
| Completed | Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated NCT04428424 | Pfizer | — |
| Terminated | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) NCT04333147 | GlaxoSmithKline | Phase 3 |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis NCT04210817 | ProgenaBiome | — |
| Completed | The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA NCT04928066 | Qilu Hospital of Shandong University | Phase 4 |
| Completed | Postprandial Inflammation in Rheumatoid Arthritis NCT04247009 | Göteborg University | N/A |
| Withdrawn | Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis NCT04115020 | Brigham and Women's Hospital | Phase 2 |
| Unknown | Prediction Medical Device for Rheumatoid Arthritis (PREDIRA) NCT04147026 | Hospital San Carlos, Madrid | N/A |
| Recruiting | Evolution and Treatments of Chronic Inflammatory Systemic Diseases NCT04191395 | Centre Hospitalier Universitaire de Besancon | — |
| Completed | Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to S NCT04134728 | GlaxoSmithKline | Phase 3 |
| Unknown | Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skill NCT04499001 | Hôpital Cochin | — |
| Unknown | Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis NCT04188249 | Peking Union Medical College Hospital | — |
| Terminated | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely A NCT03970837 | GlaxoSmithKline | Phase 3 |
| Active Not Recruiting | BIOTIPRA: BIOmarker-guided Treatment Decisions in Psoriatic and Rheumatoid Arthritis NCT03853395 | University of Manchester | N/A |
| Completed | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely A NCT03980483 | GlaxoSmithKline | Phase 3 |
| Completed | Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA NCT03589833 | Peking Union Medical College Hospital | Phase 4 |
| Completed | WORKWELL: Testing Work Advice for People With Arthritis NCT03942783 | University of Salford | N/A |
| Completed | Golimumab for Adherence in Rheumatoid Arthritis NCT03729349 | Janssen Inc. | — |
| Completed | IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis NCT03981900 | Pfizer | — |
| Completed | Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics NCT03964649 | Pfizer | — |
| Unknown | The Safety and Effectiveness of Tocilizumab in Rheumatoid Arthritis NCT04384068 | Peking Union Medical College Hospital | — |
| Completed | Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients NCT03754855 | University Hospital, Bordeaux | — |
| Completed | This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheum NCT04267614 | Pfizer | — |
| Completed | Can 4 Weeks of Exercise Program Change Quadriceps Architecture in Patients With Rheumatoid Arthritis NCT04834050 | Ovgu Bickici | N/A |
| Completed | A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day NCT04267380 | Pfizer | — |
| Withdrawn | Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthr NCT03625089 | Chinese University of Hong Kong | N/A |
| Completed | Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis NCT04056039 | Hospital Central "Dr. Ignacio Morones Prieto" | Phase 2 |
| Unknown | Fertility Study of Women With Chronic Inflammatory Rheumatism NCT03452735 | University Hospital, Toulouse | — |
| Completed | One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study NCT03662919 | Biogen | — |
| Completed | BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics NCT03540615 | Bayer | Phase 1 |
| Completed | Impact of Life Events and Psychological Stress in Rheumatoid Arthritis Set-up : Case-control Study Within a Mu NCT03550833 | University Hospital, Bordeaux | — |
| Completed | COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA NCT03649061 | P. Verschueren | Phase 4 |
| Completed | Biologic National Registry NCT03793660 | Dacima Consulting | — |
| Completed | Study of Hip and Knee Arthroplasty in South Africa NCT03540667 | University of Cape Town | — |
| Completed | Low Dose Naltrexone for Chronic Pain From Arthritis NCT03008590 | VA Office of Research and Development | Phase 2 |
| Terminated | First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Si NCT03426995 | GlaxoSmithKline | Phase 1 |
| Enrolling By Invitation | Progression of Bone Erosions in Rheumatoid Arthritis Assessed by HR-pQCT and Conventional X-ray NCT03429426 | Aarhus University Hospital | — |
| Unknown | Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders NCT03227419 | Lille Catholic University | Phase 4 |
| Unknown | Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients NCT04201535 | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | — |
| Completed | Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib NCT03387423 | Pfizer | — |
| Terminated | INFINITY™Total Ankle Replacement Follow-up NCT03277989 | Stryker Trauma and Extremities | — |
| Active Not Recruiting | Anatomical Shoulder Domelock System Study NCT03312465 | Zimmer Biomet | — |
| Completed | Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects NCT03254810 | Synermore Biologics Co., Ltd. | Phase 1 |
| Completed | Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conv NCT03264703 | Eisai Korea Inc. | — |
| Withdrawn | Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Mal NCT03241446 | Navidea Biopharmaceuticals | Phase 1 |
| Completed | Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis NCT04177173 | King Edward Medical University | Phase 4 |
| Completed | A Clinical Trial Study of Knee System in Primary Total Knee Arthroplasty in China NCT02399046 | Johnson & Johnson Medical (Suzhou) Ltd. | N/A |
| Completed | Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healt NCT03306589 | GlaxoSmithKline | Phase 1 |
| Withdrawn | Excia T Cementless EBRA Study NCT02799654 | Aesculap AG | — |
| Completed | Subject Insights to Understand Rheumatoid Arthritis (RA) NCT03285191 | GlaxoSmithKline | — |
| Completed | Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology NCT03306784 | Nantes University Hospital | — |
| Completed | Stepping Up For Inflammatory Arthritis NCT02912221 | University of Pennsylvania | N/A |
| Terminated | REMission INDuction in Very Early Rheumatoid Arthritis NCT02935387 | UMC Utrecht | Phase 4 |
| Unknown | A Single Dose Clinical Trial to Study the Safety of ART-I02 in Patients With Arthritis NCT02727764 | Arthrogen | Phase 1 |
| Terminated | Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis? NCT02908490 | Kimberly Liang | Phase 2 |
| Completed | Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modi NCT03073109 | Pfizer | — |
| Terminated | A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis NCT03161457 | JHL Biotech, Inc. | Phase 1 |
| Completed | Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects NCT03028467 | GlaxoSmithKline | Phase 1 / Phase 2 |
| Completed | Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Wi NCT02865434 | Navidea Biopharmaceuticals | Phase 1 / Phase 2 |
| Terminated | Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoi NCT02965599 | GlaxoSmithKline | Phase 2 |
| Completed | Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis NCT03337165 | Russian Academy of Medical Sciences | Phase 1 |
| Terminated | Bone MicroArchitecture Abatacept (BMA2) NCT02675218 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Completed | Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab NCT02963402 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis NCT02919761 | Mallinckrodt | Phase 4 |
| Completed | Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis NCT03495791 | Rush University Medical Center | N/A |
| Completed | Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK29827 NCT02858492 | GlaxoSmithKline | Phase 2 |
| Completed | Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to NCT02937701 | Amgen | Phase 3 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers NCT03315494 | Oscotec Inc. | Phase 1 |
| Completed | Effects of a Rheumatoid Arthritis Self-management Program NCT03470740 | Chang Gung Memorial Hospital | N/A |
| Completed | The Long-term Effectiveness of Case Management for Patients With Rheumatoid Arthritis in Taiwan NCT03446989 | Dalin Tzu Chi General Hospital | N/A |
| Completed | Exercise and Mediterranean Diet on Body Composition, Disease Activity and Inflammatory Markers in Rheumatoid A NCT02900898 | LILIA CASTILLO MARTINEz | N/A |
| Completed | Treatments Against RA and Effect on FDG-PET/CT NCT02374021 | Brigham and Women's Hospital | Phase 4 |
| Completed | Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis NCT02799472 | GlaxoSmithKline | Phase 2 |
| Unknown | Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care NCT02832297 | Crescendo Bioscience | N/A |
| Completed | Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compar NCT02792699 | Amgen | Phase 3 |
| Completed | Compare Diagnostic Performance of DIXON &CHESS Sequences Calculating RAMRIS Score in Early Rheumatoid Arthriti NCT03943563 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Active Not Recruiting | UK Infinity, Post-Market Clinical Follow-up Study NCT03063593 | Stryker Trauma and Extremities | — |
| Completed | A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy NCT02746380 | LG Life Sciences | Phase 3 |
| Completed | Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis NCT02770794 | Chiba University | Phase 4 |
| Completed | Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis NCT01961310 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in R NCT02728934 | Janssen Scientific Affairs, LLC | — |
| Unknown | The Influence of Rapid Recovery on Sleep Quality Following Total Knee Replacement Surgery NCT02845960 | Southwest Hospital, China | — |
| Completed | Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis NCT02640612 | Boehringer Ingelheim | Phase 3 |
| Completed | Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Fo NCT02636907 | Boehringer Ingelheim | Phase 2 |
| Unknown | Inhibition of Co-Stimulation in Rheumatoid Arthritis NCT02652273 | NHS Greater Glasgow and Clyde | Phase 4 |
| Completed | The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment NCT03855007 | Qilu Hospital of Shandong University | Phase 4 |
| Unknown | Supporting Patient Care With Electronic Resource (SuPER) NCT02540044 | University of British Columbia | N/A |
| Completed | Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients NCT02602704 | Hanyang University | Phase 4 |
| Completed | Characterization of Breg Cells NCT02615951 | University Hospital, Montpellier | N/A |
| Unknown | Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease NCT02742337 | Arthritis Northwest PLLC | — |
| Completed | MTX Discontinuation and Vaccine Response NCT02748785 | Seoul National University Hospital | Phase 4 |
| Completed | Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by NCT02553018 | Nordic Pharma SAS | Phase 3 |
| Terminated | A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques NCT02350426 | GlaxoSmithKline | Phase 1 |
| Completed | Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Sev NCT02504671 | GlaxoSmithKline | Phase 2 |
| Completed | Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis NCT02480946 | Modern Biosciences Ltd | Phase 1 |
| Completed | A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis P NCT02405780 | Fujifilm Kyowa Kirin Biologics Co., Ltd. | Phase 3 |
| Completed | Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? NCT02436785 | University of British Columbia | N/A |
| Unknown | Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Dis NCT03214263 | Rigshospitalet, Denmark | — |
| Unknown | Screening Protein Markers in Patients With Rheumatoid Arthritis and Hot-dampness and Blood Stasis Syndrome NCT02408094 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | — |
| Active Not Recruiting | Cardiovascular Risk and Chronic Inflammatory Rheumatism NCT03187444 | University Hospital, Clermont-Ferrand | N/A |
| Completed | Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Art NCT02378506 | Pfizer | Phase 3 |
| Completed | 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection NCT02330445 | Protalex, Inc. | Phase 1 / Phase 2 |
| Completed | Follow-up of Person-centered Care of Young Adults With Rheumatic Disease NCT02402894 | Vastra Gotaland Region | — |
| Unknown | A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therap NCT02357069 | LG Life Sciences | Phase 3 |
| Completed | BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis NCT02137226 | Boehringer Ingelheim | Phase 3 |
| Completed | The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term T NCT02837978 | Qiang Shu | Phase 4 |
| Completed | Home Monitoring of Patients With Chronic Diseases - an eRehab Test-retest Study NCT02316977 | Eva Ejlersen Wæhrens | — |
| Completed | A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients NCT02260791 | Fujifilm Kyowa Kirin Biologics Co., Ltd. | Phase 3 |
| Completed | Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study NCT02296632 | Cedars-Sinai Medical Center | — |
| Completed | Treat-to-target in RA: Collaboration To Improve adOption and adhereNce NCT02260778 | Brigham and Women's Hospital | N/A |
| Completed | Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid NCT02569736 | Association Aquitaine de Recherche Clinique en Rhumatologie | — |
| Completed | Rheumatoid Arthritis and Treatment of Periodontitis: a Randomized Clinical Trial. NCT05271890 | University of Pisa | N/A |
| Completed | A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis NCT02196558 | Eisai Co., Ltd. | Phase 1 / Phase 2 |
| Terminated | Zoledronic Acid in Rheumatoid Arthritis NCT02123264 | Carmen Gómez-Vaquero | Phase 3 |
| Unknown | Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthriti NCT02087696 | Spanish Foundation of Rheumatology | Phase 4 |
| Completed | A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of A NCT02019472 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis NCT02114931 | Amgen | Phase 3 |
| Completed | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis NCT02092467 | Pfizer | Phase 4 |
| Terminated | T and B Cell Responses in Autoimmune Diseases NCT01947036 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Art NCT01970475 | Amgen | Phase 3 |
| Completed | Immunogenicity and Safety of Vaccinations in Immunocompromised Persons NCT01947465 | University of Zurich | — |
| Terminated | A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Hav NCT01962974 | Janssen Biotech, Inc. | Phase 3 |
| Completed | This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets. NCT01750931 | GlaxoSmithKline | N/A |
| Terminated | Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male V NCT01934101 | GlaxoSmithKline | Phase 1 |
| Completed | Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO13 NCT01856309 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Study of the Influence of the Expression of the Calcium-sensitive Receptor (CaSR) by Monocytes in the Synovial NCT02894047 | Centre Hospitalier Universitaire, Amiens | — |
| Terminated | Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes NCT02236481 | Prof. Roberto Giacomelli | Phase 4 |
| Completed | Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease NCT03543488 | Federal University of Rio Grande do Sul | — |
| Terminated | Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy NCT02855801 | Centre Hospitalier Universitaire de Besancon | N/A |
| Terminated | Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis NCT01955733 | Boehringer Ingelheim | Phase 3 |
| Completed | Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy NCT02843789 | Centre Hospitalier Universitaire de Besancon | Phase 4 |
| Completed | A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who NCT01715831 | Hoffmann-La Roche | Phase 4 |
| Completed | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous NCT01751776 | Boehringer Ingelheim | Phase 1 |
| Completed | A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthri NCT01689532 | Janssen Pharmaceutical K.K. | Phase 3 |
| Completed | Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis NCT01749787 | Protalex, Inc. | Phase 1 |
| Unknown | Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis NCT01731262 | Third Affiliated Hospital, Sun Yat-Sen University | — |
| Completed | A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subc NCT01636557 | Janssen Research & Development, LLC | Phase 1 |
| Completed | A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 NCT01711814 | Astellas Pharma Global Development, Inc. | Phase 2 |
| Terminated | Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis NCT01682512 | Boehringer Ingelheim | Phase 3 |
| Completed | A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Des NCT01604343 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patien NCT01606761 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of NCT01645280 | Janssen Research & Development, LLC | Phase 2 |
| Completed | A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who NCT01554696 | Astellas Pharma Inc | Phase 2 |
| Completed | A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic D NCT01597739 | Janssen Research & Development, LLC | Phase 2 |
| Completed | Effectiveness and Safety of Physical Exercises in the Improvement of the Sleep Quality. Regarding Rheumatoid A NCT01919645 | Federal University of São Paulo | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis NCT01565655 | Astellas Pharma Global Development, Inc. | Phase 2 |
| Completed | A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase NCT01638013 | Astellas Pharma Inc | Phase 3 |
| Completed | Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid Arthritis NCT01613079 | Peking Union Medical College Hospital | Phase 2 / Phase 3 |
| Completed | Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis NCT02818361 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | N/A |
| Completed | A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid NCT01484561 | Pfizer | Phase 1 |
| Completed | An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis NCT01656278 | Professor of Rheumatology, MD, DMSci, Kim Horslev-Petersen | N/A |
| Completed | Real-world Clinical Efficacy of Abatacept in the T3 Data Registry NCT01555879 | Arthritis Northwest PLLC | — |
| Completed | A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects NCT01649999 | Astellas Pharma Inc | Phase 2 |
| Completed | A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid NCT01722617 | Central Hospital, Nancy, France | N/A |
| Completed | A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid Arthritis NCT01553305 | Aarhus University Hospital | N/A |
| Recruiting | Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis NCT00748254 | University of Michigan | — |
| Completed | Benefit of Orthopedic Navigation in the ARThroplasty of the Hip NCT01496300 | Aesculap AG | Phase 4 |
| Completed | Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background NCT01469013 | Eli Lilly and Company | Phase 2 |
| Withdrawn | Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle Ea NCT01313871 | Merck Sharp & Dohme LLC | — |
| Completed | Detection of Pathological Lymphocytes in Patients With Autoimmune Disease NCT02813083 | University of Minnesota | — |
| Completed | Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patie NCT01288287 | UCB Pharma | — |
| Completed | A Relative Bioavailability and Food Effect Study of New Formulations NCT01398475 | Eli Lilly and Company | Phase 1 |
| Completed | Ultrasound Utility in Routine Clinical Practise NCT03124225 | Barts & The London NHS Trust | — |
| Unknown | Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus NCT01471301 | Federal University of São Paulo | — |
| Completed | A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging ( NCT01313520 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral NCT01277991 | Pfizer | Phase 1 |
| Completed | Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis NCT01207453 | Brigham and Women's Hospital | Phase 4 |
| Completed | Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab NCT01197144 | Karolinska Institutet | N/A |
| Completed | A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy NCT01185353 | Eli Lilly and Company | Phase 2 |
| Completed | A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107) NCT01208181 | Organon and Co | Phase 3 |
| Withdrawn | Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA NCT01204138 | Stanford University | Phase 2 |
| Unknown | Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes NCT01154647 | Vrije Universiteit Brussel | N/A |
| Completed | Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients NCT01211678 | Biogen | — |
| Completed | Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study NCT01101555 | GlaxoSmithKline | Phase 1 |
| Terminated | Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis NCT01077531 | GlaxoSmithKline | Phase 1 |
| Completed | A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Ar NCT01313858 | Merck Sharp & Dohme LLC | — |
| Completed | Articular Sonography: Healthy Subjects Versus Rheumatoid Arthritis Patients NCT01476865 | Federal University of São Paulo | — |
| Completed | A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product Testers NCT01023100 | Pfizer | Phase 1 |
| Withdrawn | A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in R NCT00979771 | GlaxoSmithKline | Phase 2 |
| Completed | Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) I NCT01039688 | Pfizer | Phase 3 |
| Completed | Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimuma NCT01004432 | Janssen Biotech, Inc. | Phase 3 |
| Completed | Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate NCT00960440 | Pfizer | Phase 3 |
| Completed | Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthrop NCT01583465 | Joint Implant Surgeons, Inc. | N/A |
| Completed | An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despit NCT00973479 | Centocor, Inc. | Phase 3 |
| Completed | Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM St NCT00975130 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis NCT00913458 | Pfizer | Phase 4 |
| Completed | A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On O NCT00856544 | Pfizer | Phase 3 |
| Withdrawn | Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthri NCT00279461 | Indiana University | Phase 2 |
| Completed | A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injur NCT01140828 | Chinese University of Hong Kong | Phase 3 |
| Completed | Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) NCT01075711 | Merck KGaA, Darmstadt, Germany | — |
| Completed | Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan NCT00687193 | Pfizer | Phase 2 |
| Completed | A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate NCT00847613 | Pfizer | Phase 3 |
| Completed | A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis NCT00814307 | Pfizer | Phase 3 |
| Completed | A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in C NCT00808509 | AbbVie (prior sponsor, Abbott) | Phase 4 |
| Completed | Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis NCT00815906 | Pfizer | Phase 1 |
| Completed | Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis NCT00867516 | CSL Behring | Phase 2 |
| Completed | A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrex NCT00718718 | Centocor, Inc. | Phase 2 |
| Completed | Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients NCT00686868 | GlaxoSmithKline | Phase 1 |
| Completed | A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhib NCT00689728 | Eli Lilly and Company | Phase 2 |
| Completed | Phase IIIB Switching From Intravenous to Subcutaneous Study NCT00663702 | Bristol-Myers Squibb | Phase 3 |
| Completed | Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improv NCT00628095 | Pfizer | Phase 2 |
| Completed | A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis NCT00658047 | Chelsea Therapeutics | Phase 2 |
| Completed | Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis NCT00674635 | GlaxoSmithKline | Phase 2 |
| Completed | Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis NCT00565409 | Pfizer | Phase 4 |
| Terminated | Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis NCT00634933 | Pfizer | Phase 2 |
| Completed | A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rhe NCT00620685 | Pfizer | Phase 2 |
| Unknown | Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker NCT01072058 | University of Sao Paulo | Phase 4 |
| Terminated | Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequat NCT00611455 | GlaxoSmithKline | Phase 3 |
| Terminated | Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received NCT00655824 | GlaxoSmithKline | Phase 2 |
| Completed | Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid NCT00603512 | Pfizer | Phase 2 |
| Terminated | Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequat NCT00603525 | GlaxoSmithKline | Phase 3 |
| Unknown | Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication NCT00855322 | University College Dublin | Phase 2 |
| Completed | Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis NCT00596206 | Sanofi | Phase 3 |
| Completed | A Phase I Rheumatoid Arthritis Study in Healthy Volunteers NCT00539760 | GlaxoSmithKline | Phase 1 |
| Completed | Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) NCT00660647 | University of Aarhus | Phase 3 |
| Completed | A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis NCT00550446 | Pfizer | Phase 2 |
| Completed | Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis NCT00760968 | Takeda | Phase 2 |
| Completed | Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid NCT00550355 | Pfizer | Phase 1 |
| Completed | An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis NCT00896168 | Xian-Janssen Pharmaceutical Ltd. | Phase 4 |
| Completed | An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arth NCT00760669 | Janssen Korea, Ltd., Korea | — |
| Completed | Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis NCT00446784 | Pfizer | Phase 1 |
| Completed | Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550 NCT00414661 | Pfizer | — |
| Completed | Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality NCT00619177 | Boehringer Ingelheim | — |
| Completed | Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis NCT00413699 | Pfizer | Phase 3 |
| Terminated | Maraviroc in Rheumatoid Arthritis NCT00427934 | Pfizer | Phase 2 |
| Completed | Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA NCT00418717 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid NCT00413660 | Pfizer | Phase 2 |
| Unknown | Hanyang University Medical Center Arthritis Network NCT00418405 | Hanyang University | — |
| Completed | C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France NCT02886689 | Central Hospital, Nancy, France | — |
| Completed | An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis NCT00383188 | Pfizer | Phase 2 |
| Completed | Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid A NCT00440492 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 |
| Unknown | Non Alcoholic Fatty Liver Disease in Rheumatoid Arthritis NCT00394238 | Shaare Zedek Medical Center | — |
| Completed | Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen NCT00346216 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 |
| Completed | A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Sin NCT00439881 | GlaxoSmithKline | Phase 1 |
| Completed | Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients NCT00749645 | Juan C. Bertoglio, MD | Phase 2 |
| Completed | A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis NCT00393146 | GlaxoSmithKline | Phase 2 |
| Terminated | The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED) NCT00748930 | Merck Sharp & Dohme LLC | — |
| Completed | A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Des NCT00732875 | Merck Sharp & Dohme LLC | Phase 3 |